insights_auto
Why is 207940 up 5,39%?
Dive Deeperchevron_right
207940:KRX
Samsung Biologics Co Ltd
₩1 368 000,00
arrow_upward
+5,39%(+70 000,00) 1D
19 Okt., 09:45:35 GMT+9 · KRW
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 207940...
Open
₩1 290 000
High
₩1 370 000
Low
₩1 269 000
Mkt. cap
66,38 bn
Avg. vol.
49,67 k
Volume
23,76 k
P/E ratio
29,81
52-wk high
₩1 973 600
52-wk low
₩1 110 460
EPS
₩45 897
Shares outstanding
46,29 m
No. of employees
5 k
Open
₩1 290 000
High
₩1 370 000
Low
₩1 269 000
Mkt. cap
66,38 bn
Avg. vol.
49,67 k
Volume
23,76 k
P/E ratio
29,81
52-wk high
₩1 973 600
52-wk low
₩1 110 460
EPS
₩45 897
Shares outstanding
46,29 m
No. of employees
5 k
News stories
From web sources and news partners
GlobeNewswire
·
1 uur gelede
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
Simply Wall Street
·
6 minute gelede
Top Growth Stocks With Insider Buying For October 2026
www.marketscreener.com
·
22 minute gelede
Inter & Co, Inc.(NasdaqGS: INTR) added to S&P Global BMI Index
Bloomberg.com
·
2 uur gelede
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
About Samsung Biologics Co Ltd